These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 8353881

  • 21. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
    Maurer E, Tang C, Schaff M, Bourdon C, Receveur N, Ravanat C, Eckly A, Hechler B, Gachet C, Lanza F, Mangin PH.
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1221-9. PubMed ID: 23559635
    [Abstract] [Full Text] [Related]

  • 22. Flow-related platelet deposition on subendothelium.
    Weiss HJ.
    Thromb Haemost; 1995 Jul; 74(1):117-22. PubMed ID: 8578443
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].
    Gralnick HR, Williams S, McKeown L, Kramer W, Krutzsch H, Gorecki M, Pinet A, Garfinkel LI.
    Proc Natl Acad Sci U S A; 1992 Sep 01; 89(17):7880-4. PubMed ID: 1518808
    [Abstract] [Full Text] [Related]

  • 25. Cultured endothelial cells regulate platelet adhesion to their extracellular matrix by regulating its von Willebrand factor content.
    Wu YP, Sixma JJ, de Groot PG.
    Thromb Haemost; 1995 Apr 01; 73(4):713-8. PubMed ID: 7495084
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets.
    de Groot PG, Verweij CL, Nawroth PP, de Boer HC, Stern DM, Sixma JJ.
    Arteriosclerosis; 1987 Apr 01; 7(6):605-11. PubMed ID: 3318780
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.
    Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD.
    J Clin Invest; 2000 Aug 01; 106(3):385-92. PubMed ID: 10930441
    [Abstract] [Full Text] [Related]

  • 31. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP, Eidt J, Drouilhet J, Brown AT, Wang Y, Barnes CS, Moursi MM.
    J Vasc Surg; 2001 Oct 01; 34(4):724-9. PubMed ID: 11668330
    [Abstract] [Full Text] [Related]

  • 32. Axial dependence of platelet-collagen interactions in flowing blood. Upstream thrombus growth impairs downstream platelet adhesion.
    Sakariassen KS, Baumgartner HR.
    Arteriosclerosis; 1989 Oct 01; 9(1):33-42. PubMed ID: 2783548
    [Abstract] [Full Text] [Related]

  • 33. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 01; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 34. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
    Kumar RA, Moake JL, Nolasco L, Bergeron AL, Sun C, Dong JF, McIntire LV.
    Biorheology; 2006 Nov 01; 43(5):681-91. PubMed ID: 17047284
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
    Meyer D.
    Nouv Rev Fr Hematol (1978); 1982 Nov 01; 24(3):145-51. PubMed ID: 6752879
    [Abstract] [Full Text] [Related]

  • 38. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, McIntire LV.
    Circulation; 1995 Mar 01; 91(5):1354-62. PubMed ID: 7867173
    [Abstract] [Full Text] [Related]

  • 39. Fibronectin in platelet adhesion to human collagen types I and III. Use of nonfibrillar and fibrillar collagen in flowing blood studies.
    Nievelstein PF, D'Alessio PA, Sixma JJ.
    Arteriosclerosis; 1988 Mar 01; 8(2):200-6. PubMed ID: 3348760
    [Abstract] [Full Text] [Related]

  • 40. The effect of adsorbed fibrinogen, fibronectin, von Willebrand factor and vitronectin on the procoagulant state of adherent platelets.
    Grunkemeier JM, Tsai WB, McFarland CD, Horbett TA.
    Biomaterials; 2000 Nov 01; 21(22):2243-52. PubMed ID: 11026630
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.